idiopathic-pulmonary-fibrosis

Documents about idiopathic-pulmonary-fibrosis

• All-Case Surveillance of Ofev in Patients With IPF in Japan#803516ClinicalTrials.gov
• Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study#868568ClinicalTrials.gov
• The role of S100A8/A9 in the pathogenesis of acute exacerbations of pulmonary fibrosis#348398OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Recognizing the need to pursue research into the causes, a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, and for other purposes.#128935Congress.gov
• University of Virginia Natural History Study#804619ClinicalTrials.gov
• Identification of senescence-related genes in diagnosing idiopathic pulmonary fibrosis via integrating bioinformatics analysis and machine learning#437359PLOS
• Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary Fibrosis#1007046ClinicalTrials.gov
• Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants#222358bioRxiv / medRxiv
• Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative study.#315441NCBI PubMed Central
• Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect#860270ClinicalTrials.gov
• Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF#870562ClinicalTrials.gov
• Organelle Crosstalk and Metabolic Reprogramming in Idiopathic Pulmonary Fibrosis: Mechanisms and Therapeutic Implications.#659574NCBI PubMed Central
• Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects#849465ClinicalTrials.gov
• First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects#474841ClinicalTrials.gov
• Decoding the ubiquitination-immunity axis in idiopathic pulmonary fibrosis: diagnostic insights and therapeutic implications.#25727NCBI PubMed Central
• Data Management and Sharing Plan for: Metformin to Attenuate ProgressiVe RespIratory Decline in Idiopathic Pulmonary Fibrosis (MAVRIC-IPF)#297939UNC Dataverse Dataverse OAI Archive
• Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF#893250ClinicalTrials.gov
• The role of glutamine metabolism in the pathogenesis of idiopathic pulmonary fibrosis and its therapeutic potential.#975701NCBI PubMed Central
• New Diagnostic Approaches in the Management of Inflammatory Lung Diseases#887839ClinicalTrials.gov
• Medication Adherence and Non-adherence in Adults With Rare Disease#909803ClinicalTrials.gov
• Natural therapeutics and traditional formulas targeting macrophage polarization in the fibrotic niche of idiopathic pulmonary fibrosis.#371518NCBI PubMed Central
• Multi-omics integration identifies APOE as a metabolic regulator of macrophage-fibroblast crosstalk in idiopathic pulmonary fibrosis.#636248NCBI PubMed Central
• Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD#967554ClinicalTrials.gov
• Network pharmacology and integrative bioinformatics analyses identify PDE1A as a key target of pirfenidone in idiopathic pulmonary fibrosis.#3764NCBI PubMed Central
• Polygenic risk scores enhance the identification of carriers of monogenic forms of idiopathic pulmonary fibrosis#192358bioRxiv / medRxiv
• Quantitative label-free multiphoton imaging of collagen features predicts disease severity and progression in idiopathic pulmonary fibrosis.#242244NCBI PubMed Central
• Anxiety and depression symptoms, coping strategies and appraisal of living with idiopathic pulmonary fibrosis: implications for psychological support#342192HAL (France)
• Single cell transcriptomics in a treatment-segregated cohort exposes a STAT3-regulated therapeutic gap in idiopathic pulmonary fibrosis#353169bioRxiv / medRxiv
• Targeting alveolar type II cell dysfunction in idiopathic pulmonary fibrosis: Molecular mechanisms and emerging therapeutic strategies (Review).#388730NCBI PubMed Central
• Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study#680738Spiral
• Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis#886392ClinicalTrials.gov
• Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects#911418ClinicalTrials.gov
• A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications#856482ClinicalTrials.gov
• A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers#143790ClinicalTrials.gov
• Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis.#13516NCBI PubMed Central
• Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung disease#450669S-Space: Seoul National University
• RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients#893830ClinicalTrials.gov
• Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers#993701ClinicalTrials.gov
• Targeting cuproptosis: a potential new therapeutic strategy for idiopathic pulmonary fibrosis#374097Figshare
• Exposure-informed lung transcriptomic analysis links predicted NNK targets to cell type-specific remodeling programs in idiopathic pulmonary fibrosis.#420996NCBI PubMed Central
• Effects of Home-based Inspiratory Muscle Training in Patients With IPF#848540ClinicalTrials.gov
• A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects#885898ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects#1009679ClinicalTrials.gov
• Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses#130386Unpaywall
• Using SFTPC and computed tomographic volumetric imaging to diagnose and predict outcomes in usual interstitial pneumonia-type idiopathic pulmonary fibrosis.#258181NCBI PubMed Central
• To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers#893837ClinicalTrials.gov
• A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.#857894ClinicalTrials.gov
• A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension#253116ClinicalTrials.gov
• Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives#967213ClinicalTrials.gov
• Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses#126098PLOS